Dermapharm Holding SE (LON:0A5J)
London flag London · Delayed Price · Currency is GBP · Price in EUR
35.00
-0.30 (-0.85%)
At close: Jul 9, 2025

Dermapharm Holding SE Revenue

Dermapharm Holding SE had revenue of 305.26M EUR in the quarter ending March 31, 2025, with 1.27% growth. This brings the company's revenue in the last twelve months to 1.20B, up 6.20% year-over-year. In the year 2024, Dermapharm Holding SE had annual revenue of 1.20B with 3.89% growth.

Revenue (ttm)
1.20B EUR
Revenue Growth
+6.20%
P/S Ratio
1.62
Revenue / Employee
332.22K EUR
Employees
3,610
Market Cap
1.62B GBP

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 1.20B 44.72M 3.89%
Dec 31, 2023 1.15B 110.19M 10.59%
Dec 31, 2022 1.04B 80.46M 8.38%
Dec 31, 2021 960.09M 151.78M 18.78%
Dec 31, 2020 808.31M 93.94M 13.15%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
HSBC Holdings 44.89B
Shell 217.54B
Unilever 50.25B
Rolls-Royce Holdings 18.91B
British American Tobacco p.l.c. 25.87B
Rio Tinto Group 42.86B
RELX PLC 9.43B
Revenue Rankings